Premium
Another investor has joined the race to buy KKR's stake in Avendus, while a top US-based private equity firm is leading the bidding to buy a slice of Haldiram, according to media reports. Also in news, contract drugmaker Aragen is onboarding a Singapore-headquartered investor to its cap table and Yotta ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.